Viewing Study NCT03536559

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2026-01-24 @ 10:22 PM
Study NCT ID: NCT03536559
Status: TERMINATED
Last Update Posted: 2023-04-03
First Post: 2018-05-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis
Sponsor: Clene Nanomedicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing Remitting Multiple Sclerosis View
None Optic Neuropathy View
None Optic; Neuritis, With Demyelination View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gold View
None nanocrystal View
None multifocal visual evoked potential View
None full field visual evoked potential View
None low contrast vision View
None low contrast letter acuity View
None remyelination View
None demyelination View